CLINICAL UTILITY OF B-TYPE NATRIURETIC PEPTIDE (BNP) IN THE EARLY DIAGNOSIS OF HEART FAILURE: A RESEARCH-ORIENTED REVIEW

Authors

  • Asadbek Isomiddinov Second-year Master's degree student in Cardiology Fergana Medical Institute of Public Health

Keywords:

BNP, NT-proBNP, heart failure, biomarkers, early diagnosis, natriuretic peptides

Abstract

Heart failure (HF) is a major cause of morbidity and mortality worldwide, requiring early and accurate diagnosis for optimal management. Clinical evaluation alone is often insufficient due to nonspecific symptoms. B-type natriuretic peptide (BNP) has emerged as a key biomarker reflecting myocardial stress. This review evaluates the diagnostic performance, clinical applications, and limitations of BNP in early HF detection. Evidence demonstrates that BNP testing provides high sensitivity for ruling out HF and improves diagnostic accuracy, particularly in patients presenting with acute dyspnea. Integration of BNP into clinical algorithms enhances early diagnosis and risk stratification.

References

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for HF.Eur Heart J. 2021;42:3599–3726. doi:10.1093/eurheartj/ehab368

Maisel AS, Krishnaswamy P, Nowak RM, et al. BNP in emergency HF diagnosis. N Engl J Med. 2002;347:161–167.

Januzzi JL Jr, et al. Natriuretic peptide testing. Circulation. 2018;137:703–705.

Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007.

Taylor KS, et al. Natriuretic peptide diagnostic accuracy. BMJ. 2018;361:k1450.

Mueller C, et al. BNP in acute HF. Eur Heart J.

Castiglione V, et al. Biomarkers in HF. Eur J Heart Fail. 2021.

Chow SL, et al. Role of biomarkers in HF. Circulation. 2017.

Downloads

Published

2026-04-01

How to Cite

Asadbek Isomiddinov. (2026). CLINICAL UTILITY OF B-TYPE NATRIURETIC PEPTIDE (BNP) IN THE EARLY DIAGNOSIS OF HEART FAILURE: A RESEARCH-ORIENTED REVIEW. IQRO , 21(1), 9–13. Retrieved from https://wordlyknowledge.uz/index.php/iqro/article/view/5864

Issue

Section

Articles